ILDS Guidance Notes on COVID-19

The worldwide spread of the coronavirus disease (COVID-19) is a serious public health concern. It is having an impact on the way people around the world live and work.

The ILDS recognises that we all have a critical role in supporting efforts to protect individuals and populations around the world and is undertaking a number of initiatives to support the dermatological community including the development of guidance and collaborating in new dermatologic registries.

ILDS Guidance Notes on COVID-19

The ILDS is developing specific guidance where possible with regards to those with skin conditions. We are aware that a number of national and regional dermatology societies are providing their own guidance and we hope to complement this with guidance that can be an additional resource for dermatologists wherever they are based in the world.

The ILDS has issued the following guidance notes:

• Guidance on the Practice of Dermatosurgery and Cosmetic Procedures During the Covid-19 (Sars-Cov-2, Coronavirus) Pandemic (June 2020)
• Guidance on the Use of Immunomodulatory and Immunosuppressive Drugs in Dermatology in the Era of COVID-19 (May 2020)
• Guidance on the Use of Systemic Therapy for Patients with Psoriasis/Atopic Dermatitis During the Covid-19 (Sars-Cov-2, Coronavirus) Pandemic (May 2020)

International Dermatologic Registries

There have been increasing reports of dermatologic manifestations of coronavirus (COVID-19). In order to rapidly and centrally collect information from a global network of dermatologists and inform colleagues on the front line combating the virus, the ILDS is actively collaborating with the American Academy of Dermatology (AAD) and other ILDS Member organisations to promote the use of these newly developed registries. These valuable registries are aimed at helping dermatologists around the world rapidly get a better understanding of the consequences of COVID-19 for our patients and their management. Three such registries are listed below:

• Dermatologic Manifestations of COVID-19, and existing dermatologic conditions in the setting of COVID-19
• Psoriasis (PsoPROTECT registry)
• Atopic Dermatitis (SECURE-AD registry)

You can find ILDS Guidance notes and details of international dermatologic registries on our COVID-19 Hub ( www.ilds.org/covid-19).